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ATL is a highly aggresive lymphoproliferative disorder
caused by HTLV-1. While HTLV-1 proviral load
increase with progression of the disease, changes follow-
ing therapy in ATL have not been well characterized.
We present a case of ATL in complete remission with
persistent high HTLV-1 proviral load.
A 49-year-ol man was diagnosed as HTLV-1 carrier
after a blood donation in 2004. He was born in Buenos
Aires, a non-endemic area of Argentina. Four years
later, he was diagnosed with T-cell lymphoma but
rapidly blast cells were observed in peripheral blood and
it was classified as T-cell leukemia . Chemotherapy was
started in November 2008 and reached complete remis-
sion after 6 cycles. In May 2009, Interferon and zidovu-
dine was started as maintainance therapy. HTLV-1
proviral load were log10 5.5 copies/10
6 PBMCs and
log10 5.3 copies/10
6 PBMCs in September 2009 and
December 2009, respectively. Due to persistent high
proviral load, the therapy was changed to pegylated
interferon, tenofovir and lamivudine (3TC). Proviral
load levels were also high at 4 and 14 months on treat-
ment (log10 5.45 copies/10
6 PBMCs and log10 5.35
copies/10
6 PBMCs, respectively).
With the combination of interferon and reverse tran-
scriptase inhibitors for more than one year, the patient
is in complete remission, 27 month after the diagnosis,
despite the fact that he never even attained reduction of
HTLV-1 proviral load.
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